CCG
DXCM icon

Capital CS Group’s DexCom DXCM Stock Holding History

Capital CS Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,150
Closed -$714K – 112
2024
Q1 		$714K Buy
+5,150
New +$647K 0.68% 15
2023
Q1 		– Sell
-2,658
Closed -$301K – 68
2022
Q4 		$301K Buy
+2,658
New +$292K 0.33% 28

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital CS Group's DXCM Position: Q2 2024 in Review

Capital CS Group sold out of DexCom (DXCM) in Q2 2024, closing a stake of 5,150 shares — an estimated $714K sold.

Capital CS Group first reported a position in DXCM in Q4 2022 and held it in 2 quarters. The position peaked at $714K in Q1 2024. 1,000 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Capital CS Group reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Capital CS Group sold 5,150 DexCom shares in Q2 2024, an estimated $714K.
  • Capital CS Group first reported a position in DexCom in Q4 2022 and held it in 2 quarters.
  • Capital CS Group's DexCom position peaked at $714K in Q1 2024.
  • 1,000 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Capital CS Group's 13F filing for Q2 2024, filed 12 Jul 2024.